Podcast: driving linked data insights, the complexities, and experiences
This is the final episode in season one of Insights Uncovered: A Real-World Data Podcast Series from GlobalData, presented by…
Partner Content
-
-
The importance of real-world evidence in transforming healthcare decision-making
Over the last 20 years, US healthcare has shifted to a value-based system, with payers and healthcare providers being challenged…
-
Advancing pharma fulfilment in 2026: is your software up to the challenge?
Pharmaceutical and healthcare fulfilment operations are under enormous pressure, with a need to navigate multiple supply chain challenges. Scalable systems…
-
Free webinar: Ensuring compliance-first logistics for reliable clinical trials
According to GlobalData, industry-sponsored trials have increased from 7,721 in 2016 to 13, 685 in 2025. This growth over the…
-
Innovations in Dermatology Trials: Embracing Digital Tools and Decentralized Approaches
Skin disease has a growing profile in drug development. New immuno-dermatology agents, topical biologics and cell-based treatments are moving through…
-
The advantages of a platform approach in clinical trial data management
Clinical trials are producing more data than ever before, drawing from vast and diverse datasets that must be cleaned and…
-
Doubling down on efficacy: Exploring the potential of dual-payload ADCs
Chemotherapy has been our main weapon against late-stage cancers for decades, bringing with it wide-ranging side effects caused by the…
-
Trends for 2026: Targeted AI, continuous trials, and navigating uncertainty
As the clinical trial industry faces key challenges such as shifts, rising costs, and staffing challenges, 2026 is poised to…
-
Cencora: the only truly global pharmaceuticals 3PL provider
Advances in research and medical science are creating huge steps forward in the development of therapeutics for critically and seriously…
-
Vertically integrated CDMOs: The advantages and disadvantages for ADCs
Vertical integration of contract development and manufacturing organisations (CDMOs) involved in antibody-drug conjugates (ADCs) manufacturing has the potential to streamline…